Overexpression of NAC1 confers drug resistance via HOXA9 in colorectal carcinoma cells
Overexpression of NAC1 confers drug resistance via HOXA9 in colorectal carcinoma cells
About this item
Full title
Author / Creator
Ju, Tongfa , Jin, Huicheng , Ying, Rongchao , Xie, Qi , Zhou, Chunhua and Gao, Daquan
Publisher
Greece: D.A. Spandidos
Journal title
Language
English
Formats
Publication information
Publisher
Greece: D.A. Spandidos
Subjects
More information
Scope and Contents
Contents
Colorectal carcinoma (CRC) is one of the most common types of malignancy worldwide. Recently, neoadjuvant chemotherapy has become an important treatment strategy for CRC. However, treatment frequently fails due to the development of chemoresistance, which is a major obstacle for positive prognosis. However, the underlying mechanisms of chemoresista...
Alternative Titles
Full title
Overexpression of NAC1 confers drug resistance via HOXA9 in colorectal carcinoma cells
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5547960
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5547960
Other Identifiers
ISSN
1791-2997
E-ISSN
1791-3004
DOI
10.3892/mmr.2017.6986
